Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface Meniscus Prosthesis

September 06 2021

Active Implants LLC, a company that develops orthopedic implant solutions, informed that it has reached an exclusive agreement with Geistlich Pharma AG to be the exclusive Swiss distributor of the company’s NUsurface Meniscus Prothesis. The world’s first “artificial meniscus” is now available in Belgium, Germany, Israel, Italy, Switzerland, and the UK.

The NUsurface Meniscus Prothesis is an artificial meniscus made from medical grade polymer. As the result of its unique materials, composite structure, and design, NUsurface does not require fixation to bone or soft tissues.

For identifying Growth Opportunities for the Composites Market
please visit https://www.lucintel.com/composites-market.aspx

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti